0 CHECKOUT

Slovakia Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3517934
  • December 2015
  • Region: Slovakia
  • 92 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • Biotika
  • HBM Pharma
  • Imuna Pharma
  • MORE

Despite Slovakia's declining disease burden, multinational drugmakers will continue to target the country given the sizeable proportion of non-communicable diseases. Slovakia's cardiovascular drug market will prove to be the most lucrative, with cardiovascular diseases accounting for over half of deaths and the highest share of drug spending.

Headline Expenditure Projections
- Pharmaceuticals: EUR1.85bn (USD2.46bn) in 2014 to EUR1.91bn (USD2.10bn) in 2015; +3.5% in local currency terms and -14.5% in US dollar terms. Forecast unchanged from last quarter.

- Healthcare: EUR6.08bn (USD8.09bn) in 2014 to EUR6.29bn (USD6.91bn) in 2015; 3.4% in local currency terms and -14.5% in US dollar terms. Forecast revised slightly upwards from last quarter.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Biotika
  • HBM Pharma
  • Imuna Pharma
  • MORE

Table: Headline Pharmaceuticals & Healthcare Forecasts (Slovakia 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Slovakia 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Slovakia 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Slovakia 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Slovakia 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Slovakia 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Slovakia 2011-2019)

Generic Drug Market Forecast
Table: Members Of GENAS, 2015
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Slovakia 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Slovakia 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Slovakia 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Slovakia 2013-2019)

Industry Risk/Reward Index

Central And Eastern Europe Risk/Reward Index - Q1 2016

Slovakia Risk/Reward Index

Rewards

Risks

Regulatory Review

Regulatory Regime

Pharmaceutical Promotion And Advertising

Marketing Authorisation Regime

Intellectual Property Issues

Pricing Regime
Table: Indexed Price Build-Up For Prescription And Non-Prescription Medicines In Slovakia

Reimbursement Regime

Market Overview

Healthcare Sector
Table: Healthcare Resources (Slovakia 2009-2014)
Table: Healthcare Personnel (Slovakia 2009-2014)
Table: Healthcare Activity (Slovakia 2009-2014)

Health Insurance

Private Health Insurance

Recent Health Insurance Developments

Research And Development
Table: Members Of BITCET, 2011
Table: Members Of SLOVBIOTECH, 2010

Clinical Trials

Epidemiology
Table: Main Causes Of Mortality And Morbidity In Slovakia

Competitive Landscape

Research-Based Industry
Table: Members Of SAFS, 2012
Table: Multinational Market Activity

Generic Drugmakers
Table: Registered Pharmaceutical Manufacturers

Pharmaceutical Distribution
Table: ADL Members, 2012 (Manufacturers, unless otherwise indicated)

Pharmaceutical Retail Sector

Company Profile

Biotika

HBM Pharma

Imuna Pharma

Demographic Forecast
Table: Population Headline Indicators (Slovakia 1990-2025)
Table: Key Population Ratios (Slovakia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Slovakia 1990-2025)
Table: Population By Age Group (Slovakia 1990-2025)
Table: Population By Age Group % (Slovakia 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Biotika
HBM Pharma
Imuna Pharma

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.